AstraZeneca holds talks with Bristol Myers Squibb over $400bn tie-up

AstraZeneca holds talks with Bristol Myers Squibb over $400bn tie-up

Deal would create the world’s fourth-largest drugmaker by market value

Leave a Reply

Your email address will not be published. Required fields are marked *

Page Reader Press Enter to Read Page Content Out Loud Press Enter to Pause or Restart Reading Page Content Out Loud Press Enter to Stop Reading Page Content Out Loud Screen Reader Support
WordPress Cookie Plugin by Real Cookie Banner